Compound Detail
CHEMBL4174065
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
COc1cc([C@@H]2c3cc4c(cc3[C@H](OC(=O)CNC(=O)OC(C)(C)C)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1OC
Basic Information
| ChEMBL ID | CHEMBL4174065 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | KKEHVLQBJGUKRD-VUHWMDJISA-N |
6
Targets
9
Activities
1
Assay Types
0
PK Parameters
11
Publications
0
Known Names
Molecular Properties
571.6
MW (Da)
3.48
ALogP
11
HBA
1
HBD
137.1
PSA (Ų)
0.39
QED
2
Ro5 Violations
7
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 9 meas. best 8.89
Target Activity Profile
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| PC-3M | IC50 | = | 1.28 | nM | 8.89 | Cytotoxicity in human PC-3M cells assessed as inhibition of cell proliferation m... | 34098082 |
| A549 | IC50 | = | 1.6 | nM | 8.8 | Cytotoxicity against human A549 cells assessed as growth inhibition after 72 hrs... | 29886322 |
| L02 | IC50 | = | 7.3 | nM | 8.14 | Cytotoxicity against human L02 cells assessed as growth inhibition after 72 hrs ... | 29886322 |
| A549 | IC50 | = | 9.54 | nM | 8.02 | Cytotoxicity in human A549 cells assessed as inhibition of cell proliferation me... | 34098082 |
| MCF7 | IC50 | = | 11.3 | nM | 7.95 | Cytotoxicity against human MCF7 cells assessed as growth inhibition after 72 hrs... | 29886322 |
| HepG2 | IC50 | = | 26.6 | nM | 7.58 | Cytotoxicity against human HepG2 cells assessed as growth inhibition after 72 hr... | 29886322 |
| HMEC | IC50 | = | 768.1 | nM | 6.12 | Cytotoxicity in human HMEC cells assessed as inhibition of cell proliferation me... | 34098082 |
| HepG2 | IC50 | = | 50739.0 | nM | 4.29 | Cytotoxicity in human HepG2 cells assessed as inhibition of cell proliferation m... | 34098082 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 34098082 | 10.1016/j.bmcl.2021.128174 | PC-3M | 23 |
| 29886322 | 10.1016/j.ejmech.2018.05.052 | A549 | 3 |
| 29886322 | 10.1016/j.ejmech.2018.05.052 | L02 | 1 |
| 29886322 | 10.1016/j.ejmech.2018.05.052 | HepG2 | 1 |
| 29886322 | 10.1016/j.ejmech.2018.05.052 | MCF7 | 1 |
| 34098082 | 10.1016/j.bmcl.2021.128174 | HMEC | 1 |
| 34098082 | 10.1016/j.bmcl.2021.128174 | A549 | 1 |
| 34098082 | 10.1016/j.bmcl.2021.128174 | MCF7 | 1 |
| 34098082 | 10.1016/j.bmcl.2021.128174 | HepG2 | 1 |
| 34098082 | 10.1016/j.bmcl.2021.128174 | Unchecked | 1 |
| 34098082 | 10.1016/j.bmcl.2021.128174 | RAC-alpha serine/threonine-protein kinase | 1 |
Data from ChEMBL 36 via Core Engine